Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis ; volume:25 ; number:1 ; day:17 ; month:7 ; year:2021 ; pages:1-9 ; date:12.2021
Critical care ; 25, Heft 1 (17.7.2021), 1-9, 12.2021
- Urheber
-
Pařízková, Renata Černá
Martínková, Jiřina
Havel, Eduard
Šafránek, Petr
Kaška, Milan
Astapenko, David
Bezouška, Jan
Chládek, Jaroslav
Černý, Vladimír
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-021-03680-9
- URN
-
urn:nbn:de:101:1-2021102100022625643505
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pařízková, Renata Černá
- Martínková, Jiřina
- Havel, Eduard
- Šafránek, Petr
- Kaška, Milan
- Astapenko, David
- Bezouška, Jan
- Chládek, Jaroslav
- Černý, Vladimír
- SpringerLink (Online service)
Ähnliche Objekte (12)
Population pharmacokinetics of meropenem in critically ill patients
Meropenem: continuous or extended infusion?
Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients
Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study
Does Prolonged Infusion Time Really Improve the Efficacy of Meropenem Therapy? A Prospective Study in Critically Ill Patients
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
Comparative plasma and interstitial tissue fluid pharmacokinetics of meropenem demonstrate the need for increasing dose and infusion duration in obese and non-obese patients
Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
Continuous infusion of meropenem–vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance
Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
The pharmacokinetics of dexmedetomidine during long-term infusion in critically ill pediatric patients. A Bayesian approach with informative priors
Population pharmacokinetics of meropenem in critically ill patients
Meropenem: continuous or extended infusion?
Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients
Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study
Does Prolonged Infusion Time Really Improve the Efficacy of Meropenem Therapy? A Prospective Study in Critically Ill Patients
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
Comparative plasma and interstitial tissue fluid pharmacokinetics of meropenem demonstrate the need for increasing dose and infusion duration in obese and non-obese patients
Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
Continuous infusion of meropenem–vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance
Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
The pharmacokinetics of dexmedetomidine during long-term infusion in critically ill pediatric patients. A Bayesian approach with informative priors
Population pharmacokinetics of meropenem in critically ill patients
Meropenem: continuous or extended infusion?
Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients
Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study
Does Prolonged Infusion Time Really Improve the Efficacy of Meropenem Therapy? A Prospective Study in Critically Ill Patients
Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
Physiologically-based pharmacokinetic/pharmacodynamic modeling of meropenem in critically ill patients
Comparative plasma and interstitial tissue fluid pharmacokinetics of meropenem demonstrate the need for increasing dose and infusion duration in obese and non-obese patients
Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients
Continuous infusion of meropenem–vaborbactam for a KPC-3-producing Klebsiella pneumoniae bloodstream infection in a critically ill patient with augmented renal clearance
Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients